Differential	O
secretion	O
of	O
proteins	O
and	O
glycoproteins	O
by	O
livers	B-Organ
of	O
immature	O
and	O
adult	O
rats	O
.	O

Effect	O
of	O
antimicrotubule	B-Cellular_component
drugs	O
.	O

This	O
study	O
was	O
initiated	O
to	O
re	O
-	O
examine	O
reported	O
differences	O
in	O
the	O
action	O
of	O
antimicrotubule	B-Cellular_component
agents	O
on	O
plasma	B-Organism_substance
protein	O
secretion	O
from	O
livers	B-Organ
of	O
immature	O
versus	O
adult	O
rats	O
.	O

The	O
aim	O
was	O
(	O
1	O
)	O
to	O
determine	O
the	O
composition	O
and	O
to	O
monitor	O
the	O
secretion	O
of	O
various	O
plasma	B-Organism_substance
proteins	O
and	O
glycoproteins	O
from	O
liver	B-Multi-tissue_structure
slices	I-Multi-tissue_structure
labeled	O
in	O
vitro	O
with	O
specific	O
amino	O
acids	O
and	O
sugar	O
residues	O
,	O
and	O
(	O
2	O
)	O
to	O
correlate	O
observed	O
differences	O
in	O
secretion	O
of	O
these	O
proteins	O
with	O
structural	O
changes	O
in	O
the	O
hepatocytes	B-Cell
of	O
the	O
different	O
aged	O
animals	O
.	O

For	O
the	O
most	O
part	O
,	O
slices	B-Multi-tissue_structure
of	O
liver	B-Organ
from	O
fetal	B-Developing_anatomical_structure
(	O
term	O
)	O
,	O
neonatal	O
(	O
4	O
-	O
to	O
5	O
days	O
old	O
)	O
,	O
and	O
adult	O
rats	O
(	O
70	O
days	O
old	O
)	O
were	O
incubated	O
with	O
radioactive	O
amino	O
acids	O
or	O
various	O
tritiated	O
sugars	O
specific	O
for	O
N	O
-	O
linked	O
core	O
oligosaccharide	O
and	O
/	O
or	O
N	O
-	O
linked	O
terminal	O
oligosaccharide	O
chains	O
.	O

Our	O
findings	O
indicate	O
that	O
liver	B-Multi-tissue_structure
slices	I-Multi-tissue_structure
of	O
fetal	B-Developing_anatomical_structure
and	O
neonatal	O
rats	O
are	O
efficient	O
in	O
synthesizing	O
plasma	B-Organism_substance
proteins	O
including	O
fully	O
glycosylated	O
glycoproteins	O
.	O

The	O
secretion	O
of	O
glycosylated	O
and	O
nonglycosylated	O
proteins	O
believed	O
to	O
be	O
processed	O
through	O
Golgi	B-Cellular_component
complexes	I-Cellular_component
was	O
inhibited	O
to	O
the	O
same	O
extent	O
(	O
approximately	O
70	O
-	O
80	O
%	O
)	O
by	O
antimicrotubule	B-Cellular_component
agents	O
,	O
regardless	O
of	O
the	O
age	O
of	O
the	O
host	O
animal	O
.	O

However	O
,	O
other	O
proteins	O
and	O
glycoproteins	O
secreted	O
by	O
livers	B-Organ
of	O
immature	O
rats	O
were	O
found	O
to	O
be	O
relatively	O
insensitive	O
(	O
i	O
.	O
e	O
.	O
inhibited	O
to	O
only	O
30	O
-	O
40	O
%	O
)	O
to	O
the	O
action	O
of	O
various	O
antimicrotubule	B-Cellular_component
drugs	O
.	O

The	O
glycoproteins	O
were	O
found	O
to	O
lack	O
N	O
-	O
linked	O
terminal	O
sugars	O
(	O
although	O
the	O
glycoproteins	O
did	O
contain	O
N	O
-	O
linked	O
core	O
sugars	O
)	O
,	O
and	O
it	O
is	O
likely	O
that	O
the	O
drug	O
-	O
insensitive	O
proteins	O
bypassed	O
critical	O
glycosylating	O
sites	O
in	O
the	O
Golgi	B-Cellular_component
compartment	I-Cellular_component
prior	O
to	O
release	O
.	O

Overall	O
,	O
these	O
findings	O
support	O
earlier	O
data	O
showing	O
that	O
antimicrotubule	B-Cellular_component
drugs	O
have	O
a	O
special	O
impact	O
on	O
Golgi	B-Cellular_component
-	O
associated	O
events	O
in	O
liver	B-Cell
cells	I-Cell
.	O

To	O
what	O
extent	O
these	O
findings	O
are	O
related	O
to	O
the	O
action	O
of	O
microtubules	B-Cellular_component
remains	O
to	O
be	O
seen	O
.	O

